Page last updated: 2024-11-01

niclosamide and Sclerosis, Systemic

niclosamide has been researched along with Sclerosis, Systemic in 2 studies

Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.

Research Excerpts

ExcerptRelevanceReference
"Niclosamide is an oral antihelminthic drug used to treat parasitic infections in millions of people worldwide."4.98Niclosamide: Beyond an antihelminthic drug. ( Chen, W; Mook, RA; Premont, RT; Wang, J, 2018)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, W1
Mook, RA1
Premont, RT1
Wang, J1
Morin, F1
Kavian, N1
Nicco, C1
Cerles, O1
Chéreau, C1
Batteux, F1

Reviews

1 review available for niclosamide and Sclerosis, Systemic

ArticleYear
Niclosamide: Beyond an antihelminthic drug.
    Cellular signalling, 2018, Volume: 41

    Topics: Animals; Anthelmintics; Arthritis, Rheumatoid; Diabetes Mellitus, Type 2; Disease Models, Animal; En

2018

Other Studies

1 other study available for niclosamide and Sclerosis, Systemic

ArticleYear
Niclosamide Prevents Systemic Sclerosis in a Reactive Oxygen Species-Induced Mouse Model.
    Journal of immunology (Baltimore, Md. : 1950), 2016, 10-15, Volume: 197, Issue:8

    Topics: Animals; Anthelmintics; Autoantibodies; B-Lymphocytes; Bleomycin; Cells, Cultured; Cytokines; Diseas

2016